Surrozen's Upcoming Conference Presentations
Surrozen, Inc. (Nasdaq: SRZN), a pioneering biotechnology company recognized for its groundbreaking work in targeted therapeutics, is set to captivate investors at two significant healthcare conferences. These events are viewed as crucial opportunities for the company to communicate its advancements in selectively activating the Wnt pathway, a pivotal process for tissue repair and regeneration.
Schedule of Events
Chief Executive Officer Craig Parker will represent Surrozen at the following conferences:
Guggenheim’s Inaugural Healthcare Innovation Conference
Surrozen will be featured in a fireside chat scheduled for Wednesday, November 13, at 3:00 PM ET / 12N PT. This session aims to generate insights into Surrozen's strategic vision, ongoing projects, and future direction in the innovative field of biotechnology.
Stifel 2024 Healthcare Conference
An informative presentation is also planned at the Stifel 2024 Healthcare Conference on Tuesday, November 19, at 2:25 PM ET / 11:25 AM PT. This discussion will likely elaborate on specific initiatives within the company and offer details on product development timelines and the impacts expected from these advances.
Access to Presentations
Participants interested in following these events can find the live audio webcasts in the Investors section on the Surrozen website. After the events, recordings will be available to revisit the key takeaways and insights shared during the sessions.
About Surrozen
Surrozen is at the forefront of developing innovative biopharmaceuticals. The company is committed to discovering and advancing drug candidates that selectively modulate the Wnt pathway, which is crucial for the body’s natural healing processes. A current focal point of their research includes addressing severe liver and eye diseases through the development of tissue-specific antibodies. By leveraging the body's existing repair mechanisms, Surrozen seeks to provide novel solutions to previously challenging medical conditions.
Significance of the Conferences
Participating in these high-profile healthcare conferences allows Surrozen to engage directly with investors and stakeholders. The discussions will center around the company’s striking advancements in research and development and how these might translate into effective treatments for critical diseases. With continuous progress in their projects, Surrozen is positioned to potentially make significant contributions to the biopharmaceutical landscape.
Investor and Media Contact
For further inquiries or more information, interested parties may contact Surrozen's investor relations via email at Investorinfo@surrozen.com. This provides an avenue for investors and media representatives to obtain additional insights into the company’s initiatives and operational strategies.
Frequently Asked Questions
What is Surrozen?
Surrozen Inc. is a biotechnology company focused on developing targeted therapeutics that activate the Wnt pathway for tissue repair and regeneration.
When are the upcoming healthcare conferences?
The Guggenheim Healthcare Innovation Conference is on November 13, while the Stifel Healthcare Conference takes place on November 19.
How can I access the conference presentations?
Webcasts for the conferences can be accessed via the Investors section on Surrozen’s website.
What is the focus of Surrozen's research?
Surrozen specializes in creating tissue-specific antibodies to treat severe conditions affecting the liver and eyes by engaging the body’s natural repair mechanisms.
How can I contact Surrozen for more information?
For inquiries, you can email Surrozen’s investor relations at Investorinfo@surrozen.com.
